Concepedia

Publication | Open Access

Folfirinox <i>versus</i> gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study

DOIFull Paper Access

67

Citations

21

References

2019

Year

Nicolas Williet, Angélique Saint, Anne‐Laure Pointet, David Tougeron, Simon Pernot, Astrid Pozet, Dominique Béchade, Isabelle Trouilloud, Nelson Lourenço, Vincent Hautefeuille,
Therapeutic Advances in Gastroenterology

Abstract

This study shows greater OS with FFX than with GN in patients with mPC. GN after FFX failure appears more feasible than the reverse sequence.

References

YearCitations

Page 1